Scales (COA), as crucial clinical measurement tools, involve corresponding scientific norms and procedures in their application process, including scale selection, acquisition, and utilization. Consultation and guidance from a professional team are necessary to ensure the scientific application of these scales and to mitigate copyright and compliance risks. The Xincere Scale Consultation and Service Team provides the relevant parties in the clinical research industry with professional and convenient solutions for scale application.
To meet compliance requirements for scale usage in various scenarios, obtain scale authorization licenses efficiently, conveniently, and accurately.
Electronic data collection methods can reduce burdens while improving the quality of data collection.
The team of senior experts provides optimal solutions for scale selection in different fields.
To ensure consistency in reliability, validity, and equivalence before and after language validation of the scale.
Reducing subjectively-induced scoring errors, unifying the use and scoring criteria of scales, and enhancing data quality.
Experienced raters conduct central scoring to ensure consistency and standardization in scale assessments.
Scale Management & Service
Verified eCOA Library
Studies
Collaboration with Copyright Holders
Therapeutic areas
Clinical research field professional scale information platform in China ChineCOA Officially Launched
In order to standardize and popularize the application of scales in China and make scale information and services accessible, ChineCOA, through a collaborative approach, assists more sponsors, doctors, researchers, and industry practitioners in understanding and applying scales, providing more scientific and effective data for clinical research.
Currently, the platform has indexed over 200 scales covering therapeutic areas such as oncology, central nervous system, respiratory, dermatology, ophthalmology, otolaryngology, gynecology, and more. In the future, the database will continue to be updated and expanded.
Our Partner
